Claims-Based Quality Measures CMS Physician Group Practice Demonstration Project Chealsea Nather 26 January 2005.

Slides:

Advertisements

Similar presentations

Kentucky Regional Extension Center Your EHR Resource Contact: Dr. Martha Riddell and Dr. Carol Ireson Meaningful Use Advisors, Kentucky REC

Advertisements

CMS Final Rules: Meaningful Use Criteria VITL Webinar August 5, 2010 Tonya H. Howard, MSN, FNP-C VITL Clinical Consultant.

DIABETES AND THE KIDNEYS

Diabetes Recognition Program (DRP)

IDC 4.1 Problems n High incidence and prevalence of diabetes n Reliance on primary care providers n Significant variation in practice n High costs and.

US Health Care: Half Right. Thomas L. Garthwaite, MD Director and Chief Medical Officer Department of Health Services County of Los Angeles USC Health.

Focusing on Key Clinical Areas for Improvements: 10 Selected Topics What to do? Mike Davies, MD FACP.

Al-Fada AA & Bin Abdulrahman KA, King Saud University, Riyadh, Saudi Arabia Assessment of Care for Type 2 Diabetic Patients at the PHC Clinics of a Referral.

Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.

Jeph Herrin, PhD 1,2 Phil Aponte, MD 3 Briget da Graca, JD, MS 3 Greg Stanek, MS 3 Terianne Cowling, BA 3 Cliff Fullerton, MD, MSc 4 Priscilla Hollander,

Making Your Doctor Visit Count. Have a Medical Checkup Every 3–6 Months.

The ABC’s of PQRI in the SNF/NF setting. The ABC’s of PQRI Carolinas Medical Directors Assn. conference 10/9/2009 Rod Baird – presenter –President.

Using the AOA CAP for CMS’ Physician Quality Reporting Initiative (PQRI) Sharon L. McGill, MPH Director AOA Dept. of Quality and Research November 4, 2009.

APPENDIX 1. D-1 New cases of diagnosed diabetes D-2.1 All cause mortality* D-2.2 Cardiovascular disease deaths* D-3 Diabetes death rate, multiple cause.

Saeed A. Khan MD, MBA, FACP © CureMD Healthcare ACOs and Requirements for Reporting Quality Measures © CureMD Healthcare Saeed A. Khan MD, MBA, FACP.

Current Status and Vision for SETMA Diabetes Dr Jaweed Akhter.

Redwood Community Care Organization Data Capture for ACO Quality Measures.

MU - Selection & Configuration of Measures August 28, 2015 Presenter: Christy Erickson.

Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.

Data Input Manual ACO Specific Quality Measures. Table of Contents Selection of Attributed ACO Patient…………………………………………………………...…….1 Section of Proper.

EHR for Meaningful Use Clinical Quality Measures Dr. Aneel Advani Associate Director for Informatics IHS Office of Information Technology Indian Health.

Rapid E clinical guidance in the management of Type 2 diabetes New Zealand Guidelines Group.

Criteria for Diagnosis of DM * Testing must be repeated on separate day. FPG is the preferred test ** Symptoms of DM IFG = Impaired fasting glucose IGT.

Standard 3: Care Management a.) Guidelines for important conditions.

Diabetes Mellitus Ibrahim Sales, Pharm.D. Assistant Professor of Clinical Pharmacy King Saud University

The Culture of Healthcare

Diabetes Recognition Program (DRP) June DRP Workshop June 2010 NCQA Overview NCQA Recognition Programs DRP Application & Survey Process Benefits.

Nursing Management of Clients with Stressors of Circulatory Function HYPERTENSION NUR133 LECTURE # 10 K. Burger MSEd,MSN, RN, CNE.

Steven M. Wright, PhD Director of Epidemiology Office of Quality and Performance An Analysis of the Quality of Care Provided to Men and Women in the VA.

Management of Type 2 Diabetes New Zealand Guidelines Group.

BETH ISRAEL DEACONNESS DATA WAREHOUSE PROJECT February 27, 2009.

Basma Y. Kentab. Aggressive comprehensive risk factor management: Improves survival, Reduces recurrent events and Reduces need for interventional procedures,

Using Healthy Heart Data by Rick Frey, PhD Toiyabe Indian Health Project, Inc. A collection of PowerPoint slides that have been used in grant applications,

Standards of Medical Care for Patients with Diabetes Mellitus John Guzek, MD March 2003.

1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.

Shadi Al-Ahmadi. The Presentation will include: Hypertension Dyslipidemia CVD Type 2 Diabetes-Associated Retinopathy Diabetic Periphral Neuropathy Diabetic.

Use of Information Technology for Precision Performance Measurement and Focused Quality Improvement David W. Baker, MD MPH Chief, General Internal Medicine.

1 EFFECT STUDY 2 EFFECT STUDY  Set national cardiac care benchmarks for hospitals to work towards 

Ambulatory Care Quality Measures: Disease Management Research Opportunities Neil Goldfarb Director of Research and Research Assistant Professor of Health.

Dyslipidemia.  Dyslipidemia is elevation of plasma cholesterol, triglycerides (TGs), or both, or a low high- density lipoprotein level that contributes.

Diabetes Mellitus Primary Care QI Project – Year III Mary Altier, RN, Bonnie Fiala-Bayser, Ph.D., William Cannon, MD, David Goldberg, MD, Jan Jandrisits,

ABSTRACT Diabetes is a public health issue of growing magnitude. It currently ranks among the top ten leading causes of death in the United States. To.

Introduction to Core Measures

Comprehensive Diabetes Care. Comprehensive Diabetes Care: HbA1c Testing (Commercial) Source: National Committee for Quality Assurance, The State of Health.

HITECH/MEANINGFUL USE Danielle Smith Trends and Issues in Healthcare December 2, 2014 Power Point Project.

Diabetes and the Eye Karen B. Saland, M.D. August 18, 2008.

Component 2: The Culture of Health Care Unit 7: Quality Measurement, Performance Improvement, and Incentive Payment Schemes Lecture 4 This material was.

Quality Measurement and Improvement Component 2 / Unit 7d.

April 15, /23/ Community Health Centers (CHCs) are community owned and operated, non-profit businesses that provide access to quality primary.

January 2013 Webinar: “Practical Ways to Help Get Our Diabetes Patients to Goal” Controlling the ABC’s Cases.

The Role of Health Information Technology in Implementing Disease Management Programs Donald F. Wilson, MD Medical Director Quality Insights of Pennsylvania.

Racial Comparisons of Diabetes Care and Intermediate Outcomes in a Patient-Centered Medical Home Featured Article: Joseph A. Simonetti, Michael J. Fine,

February 2013 Webinar: “Practical Ways to Help Get Our Diabetes Patients to Goal” Controlling the ABC’s Cases.

Electronic patient record since SDC Quality of Care Data 2009 – 2011 for Type 1 Diabetes NCQA indicatorGoal HbA1c > 9,0 %≤ 15%

Free Powerpoint Templates Page 1 Using Data to Guide Improvement Presented by: Brooke Thomas, Program Advisor February 28, 2013.

Promoting Health Information Technology Linda Magno Director, Medicare Demonstrations Group.

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Presidential address: quality of cardiovascular.

If I Ran the Zoo: Quality Measures in Accountable Care and the Fit with Integrative Health and Medicine. Jim Whedon, DC, MS Research Working Group,

Evaluation Issues: NH Multi-Payer Medical Home Pilot

Redefining Quality Care in T2DM Patients with CV Disease

Fig ACCF/AHA Guideline for the management of heart failure

ACCORD Design and Baseline Characteristics

At the end of this talk, the resident will be able to:

Diabetes Health Status Report

Part 3 of 3 Welcome to this presentation on “Quality Measures in Cholesterol and Diabetes Management.” 1.

CPT 2 Coding Review Jim Barr, MD

Physician Group Practice Transition Demonstration

Diabetes: The 2007 Guidelines

RCHC’s Cardiovascular Health Initiative

Percentage of patients with type 2 diabetes with A1C < 7% (n = 248), blood pressure > 130/80 mmHg (n = 248), and LDL cholesterol < 100 mg/dl (n = 207)

Presentation transcript:

Claims-Based Quality Measures CMS Physician Group Practice Demonstration Project Chealsea Nather 26 January 2005

Year 1 Quality Measures DM-1: HbA1c Management Percentage of patients with one or more A1c test(s) DM-2: HbA1c Management Percentage of patients with most recent A1c level > 9.0% (poor control) DM-3: Blood Pressure Management Percentage of patients with most recent BP M 140/90 mm Hg DM-4: Lipid Measurement Percentage of patients with at least one low-density lipoprotein (LDL) cholesterol test DM-5: LDL Cholesterol Level Percentage of patients with most recent LDL cholesterol < 130 mg/dl DM-6: Urine Protein Testing Percentage of patients with at least one test for microalbunim during the measurement year; or who had evidence of medical attention for existing nephropathy (diagnosis of nephropathy or document of microalbuminuria or albuminuria)

Year 1 Quality Measures DM-7: Eye Exam Percentage of patients who received a dilated eye exam or evaluation of retinal photographs by an optometrist or ophthalmologist during the reporting year, or during the prior year if patient is at low risk for retinopathy. A patient is considered low risk if all three of the following criteria are met: (1) the patient is not taking insulin; (2) has an A1c < 8.0%; and (3) has no evidence of retinopathy in the prior year. DM-8: Foot Exam Percent of eligible patients receiving at least one complete foot exam (visual inspection, sensory exam with monofilament, and pulse exam). PC-7: Influenza Vaccination The percentage of diabetic patients who received an influenza vaccination from September through February of the year prior to the measurement year. PC-8: Pneumonia Vaccination The percentage of diabetic patients,65 years and older, who ever received a pneumococcal vaccination.

Year 1 Quality Measures DM-7: Eye Exam Percentage of patients who received a dilated eye exam or evaluation of retinal photographs by an optometrist or ophthalmologist during the reporting year, or during the prior year if patient is at low risk for retinopathy. A patient is considered low risk if all three of the following criteria are met: (1) the patient is not taking insulin; (2) has an A1c < 8.0%; and (3) has no evidence of retinopathy in the prior year. DM-8: Foot Exam Percent of eligible patients receiving at least one complete foot exam (visual inspection, sensory exam with monofilament, and pulse exam). PC-7: Influenza Vaccination The percentage of diabetic patients who received an influenza vaccination from September through February of the year prior to the measurement year. PC-8: Pneumonia Vaccination The percentage of diabetic patients,65 years and older, who ever received a pneumococcal vaccination.

Year 2 Quality Measures CAD-1: Antiplatelet TherapyHF-1: Left Ventricular Function (LVF) Assessment CAD-2: Drug Therapy for Lowering LDL Cholesterol HF-2: Left Ventricular Ejection Fraction Testing CAD-3: Beta Blocker Therapy – Prior MIHF-3: Weight Measurement CAD-4: Blood PressureHF-4: Blood Pressure Screening CAD-5: Lipid ProfileHF-5: Patient Education CAD-6: LDL Cholesterol LevelHF-6: Beta-Blocker Therapy CAD-7: ACE Inhibitor TherapyHF-7: ACE Inhibitor Therapy PC-7: Influenza Vaccination for HF patients. HF-8: Warfarin Therapy for Patients with Atrial Fibrillation PC-8: Pneumonia Vaccination for HF patients

Year 3 Quality Measures HTN-1: Blood Pressure Screening HTN-2: Blood Pressure Control HTN-3: Plan of Care PC-5: Breast Cancer Screening PC-6: Colorectal Cancer Screening